France's Minvasys releases Nile stent on market:
This article was originally published in Clinica
Minvasys, a French manufacturer and marketer of coronary balloons, stents and the proprietary vascular access system SuperKetch, has launched Nile, an intracoronary stent designed for easy and secured access to bifurcated arteries for the treatment of plaque. The product, described as a smart and simple device, has a specific delivery system for bifurcation lesions. It allows for the treatment of both the main and side branches simultaneously or sequentially. It was CE-marked in March 2004. The product addresses the 20% of the population with coronary diseases that have lesions at bifurcations, says Minvasys, which is based in Gennevilliers, in the Paris area. Minvasys has been in operation for one year, having been formed in May 2003.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.